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Abstract: 
Purpose: Orofacial manifestations of Lyme disease can affect head and neck anatomical structures that are frequently 
examined by dental professionals. The purpose of this systematic review was to examine the literature for types and frequencies 
of orofacial manifestations documented in populations in the United States (US) with Lyme disease.  
Methods: Four electronic databases (Dentistry and Oral Sciences, PubMed, Cinahl Plus, and Medline) were systematically 
searched during the summer of 2019 using keywords and MeSH terms to identify relevant studies. Search term alterations and 
synonyms were cross-checked using the US National Library of Medicine Unified Medical Language System Metathesaurus. 
Full-text, English language studies were included if they reported on US populations with Centers for Disease Control 
and Prevention confirmed cases of Lyme disease. The review followed guidelines set forth in Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis (PRISMA). Quality was assessed with a modified version of the Cochrane Data 
Collection Form for Randomized Control Trials and Non-randomized Control Trials.  Extracted data was organized by 
themes of manifestations and the frequencies were calculated.  
Results: An initial search extracted 217,381 articles; 43 met the inclusion criteria and were further reviewed for quality. 
Twelve articles published from 1992-2017 were deemed appropriate for inclusion. All were from non-dental journals and 
fewer than half (n=6) reported on Lyme disease endemic states. Eight incidences of orofacial manifestations within head/
neck regions were documented in Lyme disease patients (n=951) and included: headache (39.5%), facial palsy (42.5%), 
temporomandibular joint arthralgia (42.0%), altered taste (11.0%), stiff neck (13.6%), sore throat (3.0%), neck pain/arthralgia 
(7.5%), and erythema migrans rash (5.2%).  
Conclusion: Eight orofacial manifestations of Lyme disease were revealed by this systematic review.  Future research 
regarding the orofacial manifestations of Lyme disease is needed so this medical condition can be better understood by oral 
health care providers and result in improved health outcomes for infected patients. 
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Introduction
Lyme disease, the most common vector-borne disease in 
the United States (US), is transmitted by ticks infected with 
Borrelia burgdorferi sensu stricto (Bbss) or Borrelia mayonii.1 
Carriers of the pathogen include Ixodes scapularis (commonly 
known as the deer tick or blacklegged tick), and Ixodes pacificus 
(commonly known as the western blacklegged tick).2 The Bbss 
spirochetal bacterium is transferred to human hosts during 
the blood meal of an infected tick, with the incubation period 
in humans, prior to symptom onset, ranging from three to 
thirty days.3,4 First recognized in Connecticut in the 1970s, 
Lyme disease was added to the National Notifiable Disease 
Research
Surveillance System in 1991.1,5 Since then, the number of 
reported cases and geographical distribution of the disease 
has quickly spread across the country and is now considered 
endemic in 14 states including Connecticut, Delaware, Maine, 
Maryland, Massachusetts, Minnesota, New Hampshire, New 
Jersey, New York, Pennsylvania, Rhode Island, Vermont, 
Virginia, and Wisconsin.1,5 States that share a border or 
are located between high endemic states, are classified as 
“neighboring states” and are also showing an increased 
incidence of confirmed cases.5 Over 275,000 cases of Lyme 
disease were reported to the Centers for Disease Control 
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(CDC) from 2008-2015.5 Currently, state health departments 
report 30,000 new cases of Lyme disease to the CDC each 
year;2 however, the number of reported cases is estimated to be 
much lower than the number of diagnosed cases – potentially 
by ten-fold.1,6 The increasing incidence of this infectious disease 
is of growing concern, and as members of interdisciplinary 
health care teams oral health care professionals need to be 
aware of the signs and symptoms. 
Lyme disease affects multiple body organs, and if left 
untreated can potentially be life threatening; obtaining an early 
diagnosis through interprofessional care is critical.  The CDC 
is asking all health care providers to educate themselves about 
the full range of the presenting signs and symptoms of Lyme 
disease to minimize the morbidity of the disease.3,4 When 
diagnosed and treated early, patients can be successfully cured 
and report fewer residual complications.5 However, obtaining 
an early diagnosis for this complex disease is difficult in many 
cases due to the limitations of serological tests coupled with the 
onset of signs and symptoms that can vary significantly from 
person-to-person and also mimic a multitude of other ailments 
depending on the dissemination stage.3,4,6
The localized early stage may appear within 3-30 days after 
an infected tick bite and typically begins with an expanding 
skin lesion, erythema migrans, commonly known as the bull’s 
eye rash.4 Erythema migrans is considered to be a critical sign 
of Lyme disease and is often used to make a clinical diagnosis. 
However, the rash only appears in 70-80% of cases and may 
be missed if it presents on the back half of the body, on darker 
skin tones, or has an atypical appearance.4 Early stages may 
also include fever, chills, headache, fatigue, muscle and joint 
aches, and lymphedema.4 During the disseminated stage, 
seven days to several months after the initial infection, signs 
and symptoms may include severe headaches, neck stiffness, 
additional erythema migrans lesions, arthritis, and facial 
palsy.4  Individuals may also experience nerve pain, problems 
with short-term memory, irregular heartbeat, inflammation 
of the brain and spinal cord, shooting pains, numbness, and/
or tingling in the hands or feet.4 The signs and symptoms 
may appear atypical or not at all, further complicating the 
ability to obtain a timely diagnosis. Orofacial manifestations 
of Lyme disease have appeared in the health care literature, 
but they have not been a research focus despite reports 
indicating that orofacial manifestations may be the first signs 
and symptoms to appear.7 The possibility of Lyme disease 
should be a consideration for oral health care professionals 
when patients present with unexplained facial paralysis,8-17 
neck stiffness,11,13,15,18 headache,8-13,15-19 TMJ pain,10,13 altered 
taste,19 sore throat,12 and neck pain,10,12,13,17,19 when a clinical 
examination fails to identify a specific oral health pathology. 
The orofacial manifestations of Lyme disease affect head 
and neck anatomical areas that are routinely examined by 
oral health care professionals. A 2014 study found that 46% 
of surveyed health care providers had encountered a Lyme 
disease patient, and the researchers concluded that health 
care providers in general required more education about 
Lyme disease in order to promote an early diagnosis.20 This 
also points to the possibility that many dental professionals 
may be unaware of the orofacial manifestations linked to 
Lyme disease. This missed opportunity for making a timely 
diagnosis may allow the disease to progress to later stages 
characterized by chronic suffering and life-threatening 
conditions that are difficult to treat, negatively affecting 
the patient’s quality of life. Furthermore, patients often 
experience frustration when seeking a diagnosis due to health 
care professionals who may be disrespectful and dismissive 
because of not being well educated in the signs and symptoms 
of Lyme disease.21 It is important for dental professionals to 
be aware of the orofacial manifestations of Lyme disease 
and to have a referral and follow-up plan with primary care 
physicians to achieve the best possible health outcomes for 
their patients. The purpose of this systematic review was to 
examine the literature to identify the frequencies of orofacial 
manifestations documented in Lyme disease patients in the 
US to help inform oral health care providers of the orofacial 
manifestations of the disease.
Methods
This systematic review followed the guidelines set forth in 
PRISMA (Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses).22 An electronic search of the literature 
was conducted by a university health and life sciences librarian 
from May 2019 until October 2019 and included the following 
databases: Dentistry and Oral Sciences Source (EBSCO), 
PubMed (first search), Cinahl Plus with Full Text (EBSCO), 
and Medline (first search) for articles published from January 
1990 to October 2019. Several search term alterations were 
used and synonyms for the key search terms were cross-
checked using the United States National Library of Medicine 
Unified Medical Language System Metathesaurus®.23 The 
search strategy used keywords and MeSH terms that included 
terminology and synonyms for Lyme disease, vector, pathogen, 
head/neck anatomical landmarks, and orofacial manifestations. 
The search was limited to peer-reviewed journals, articles which 
included populations of Lyme disease patients diagnosed in 
accordance with CDC protocol in the US, and full-text articles 
in the English language. Articles were included if they met the 
following criteria: 1) Studies that include populations from the 
US, 2) available in full-text and in the English language, and 3) 
confirmed CDC diagnosis of Lyme disease. Exclusion criteria 
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included: 1) studies of non-US populations, 2) studies involving 
animal subjects, 3) tick-borne diseases other than Lyme disease, 
and 4) studies that did not confirm a Lyme disease diagnosis.
A citation managing system (EndNote X9; Clarivate 
Analytics, Philadelphia, PA) was utilized to organize identified 
articles. There were no limits on study designs, but grey 
literature and letters to editors were excluded. Retrieved articles 
were independently reviewed for appropriateness based on titles 
and abstracts by two researchers (BB and KJ). Meetings for 
discussion were held to resolve disagreements that were settled 
by consensus. Risk of bias was assessed independently by BB and 
KJ, and data extraction was completed using a modified version 
of the Cochrane Data Collection Form for Randomized Control 
Trials and Non-randomized Control Trials and meetings were 
held to resolve disagreements by consensus.
Results
An initial search of the databases produced a total of 
217,381 results after filters and limits based on inclusion/
exclusion criteria were applied.  The titles and abstracts were 
further filtered based on exclusionary criteria, resulting in 
744 articles to be reviewed. Ninety-five were removed due to 
duplication, yielding 649 articles. Two reviewers (BB and KJ) 
independently screened each of the 649 articles by titles and 
abstracts to identify additional articles that should be excluded 
due to a lack of relevancy; disagreements were settled by 
consensus, resulting in the removal of 441 articles. Exclusions 
based on titles and abstracts were made for the following 
reasons: published before 1990, orofacial manifestations were 
not addressed, articles were not accessible, letters to editors, 
not peer-reviewed, full text not available, only available as 
a research poster, and non-human research. The remaining 
full-text articles (n=208) were further independently reviewed 
based on inclusion/exclusion criteria and risk of bias, resulting 
in the removal of 196 articles after disagreements were settled 
by consensus. Articles were rated as poor, fair, or good based 
on the risk of bias tool (Table I). Articles removed due to risk 
of bias (n=31) included case studies, and literature reviews 
that did not report data collected from human subjects. Items 
determined to be “fair” or “poor” were included if relevant 
data was reported. Articles removed for not meeting the 
inclusion criteria (n=165) included those that were foreign, 
did not follow CDC serological protocol, and articles that did 
not report results of Lyme disease from patients with orofacial 
manifestations. Clinical trials meeting inclusion/exclusion 
criteria were not identifiable.   
A total of twelve articles were judged as being acceptable 
for inclusion in the systematic review for synthesis. Seven 
(58%) of the included studies were from the 1990s,10-13,16,17,19 
three (25%) from the 2000s,8,15,18 and two (17%) were from the 
2010s.9,14 Publication sources for the twelve articles included 
several journals: The Journal of Clinical Microbiology (2),18,19 
The New England Journal of Medicine (2),11,12 Pediatrics (2),8,9 
The American Journal of Otology (1),16 Otology & Neurotology 
(1),15 The Journal of Pediatric Infectious Diseases Society (1),14 
The American Journal of Medicine (1),13 Neurology (1),17 and 
The American Journal of Otolaryngology (1).10 The PRISMA 
flow chart of the results of included and excluded studies is 
shown in Figure 1.   
Data extraction of the included articles was completed 
independently by BB and KJ to include the first author, 
year, demographic information of the study populations, 
confirmation of Lyme disease, and presence of orofacial 
manifestations. Articles included for synthesis documented 
orofacial manifestations of Lyme disease in human patient 
populations in the endemic states of Delaware (25%, n=3),8-10 
Massachusetts (33%, n=4),9,11,14,15 Pennsylvania (17%, n=2),9,10 
New Jersey (8%, n=1),10 Connecticut (25%, n=3),12,15,19 and 
New York (42%, n=5).13,16-19 Demographic characteristics 
of the patient populations varied in the twelve studies. All 
articles included both males and females, however nine 
included mostly males (75%, n=9),8-13,15-17 only two articles 
were predominately of female populations (17%, n=2),18,19 
and one article did not make a clear distinction.14 The age 
ranges of the studied populations also varied. Six articles 
included a mixture of ages from childhood to adulthood 
(50%, n=6),10-13,15,16,19 four included children and adolescents 
(33%, n=4),8,9,14,17 and one focused only on adults (8%, n=1).18 
Six of the studies were retrospective (50%, n=6),8-10,14-16 five 
were prospective (42%, n=5),11-13,18,19 and one followed an 
Table I. Risk of bias ratings for 12 included articles
Article (year): Risk of bias rating:
Avery (2006)8 Fair
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observational design (8%, n=1).17 In half of the articles (50%, 
n=6), the number of times orofacial manifestations appeared 
was more than that of the number of total patients;10,11,15-17,19 
in one article they appeared the same number of times (8%, 
n=1),14  and in five articles they appeared only slightly less 
(42%, n=5).8,9,12,13,18 Patient demographics and the frequency 
of orofacial manifestations by article are shown in Table II.
Eight orofacial manifestations were reported among 
the included articles: headache,8-13,15-19 facial palsy,8-17,19 
temporomandibular joint arthralgia,10,13 altered taste,19 stiff 
neck,11,13,15,18 sore throat,12 neck pain/arthralgia,10,12,13,17 and 
erythema migrans rash on the head or neck.12 The frequencies 
of orofacial manifestations per study are shown in Figure 2. 
Among the twelve included articles, there were a total of 951 
confirmed cases of Lyme disease. The frequencies of the eight 
orofacial manifestations among those confirmed cases were 
reported as follows: headache (39.5%, n=376),8-13,15-19 facial 
palsy (42.5%, n=404),8-17,19 temporomandibular joint arthralgia 
(.42%, n=4),10,13 altered taste (.11%, n=1),19 stiff neck (13.6%, 
n=129),11,13,15,18 sore throat (3.0%, n=29),12 neck pain (7.5%, 
n=71),12,13,17,19 and erythema migrans rash on the head or neck 
(5.2%, n=49).12 The frequencies of orofacial manifestations 
per study are shown in Table III.
Discussion:
The scientific literature was systematically reviewed to 
synthesize information regarding the orofacial manifestations 
of Lyme disease that would be most relevant to oral health 
care providers. Studies that met the inclusion criteria from 
1992-2017 were published in journals that do not target the 
dental professional audience. There is a need for this timely 
research to appear in dental and dental hygiene journals so 
that the oral health care community is informed regarding 
the various ways this growing infectious disease may be 
manifested within their patient populations. Additionally, 
none of the included research studies discussed clinical 
assessments or scales that could be used to quantify the 
severity of Lyme disease related orofacial manifestations. 
Such diagnostic tools along with recommendations on how to 
best manage the orofacial manifestations to ease discomfort, 
improve function, and track recovery or relapse would be 
beneficial to oral health care professionals.  
Fewer than one half (n=6) of the US endemic states 
(n=14) were represented in the included studies. More 
studies are needed in the literature from other endemic and 
neighboring states, especially since the CDC Morbidity and 
Mortality Weekly Report concluded that incidence rates are 
increasing in neighboring states.5 Oral health care providers 
who practice in those geographic areas need to have evidence-
based information regarding how to care for affected patient 
populations. The literature also does not report orofacial 
manifestations evenly across demographics. Since disease 
transmission does not discriminate between genders, studies 
are needed to fully represent both males and females. An 
underrepresentation of females in the literature may be of 
concern especially for those residing in low incidence states, 
since Lyme disease has been found to be more common 
among females in states with low incidence rates.5
A total of eight orofacial manifestations were documented 
in the included studies. Half of the studies reported higher 
frequencies of these manifestations than the total number of 
study participants likely due to participants who experienced 
multiple oral manifestations. Regarding patients who present 
with orofacial symptoms of unknown origin, oral health 
care providers should carefully document their findings 
following a thorough health history interview and extra/
intraoral examination. Questions that may assist dental 
hygienists and dentists while conducting a health history 
interview when Lyme disease infection is suspected could 
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Figure 1. PRISMA Flowchart of article retrieval and  
study selection
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include: “Have you noticed a red, circular skin rash?”, “Have 
you worked or played outdoors within the last month?”, “Do 
you recall a recent insect bite?”, “Have you recently traveled 
to states known to be endemic for Lyme disease?”, and “Have 
you been tested by your medical physician for Lyme disease?”.4 
Occurrences of these orofacial manifestations should be taken 
into consideration for any type of differential diagnoses when 
the typical oral pathologies of trauma or infections cannot be 
identified. This is particularly important since these presenting 
signs and symptoms can occur during the localized early stage 
of Lyme disease when serology testing may fail.  
Eight of the included studies reported headache, neck pain/
arthralgia, sore throat, facial paralysis, stiff neck, altered taste, 
and TMJ arthralgia as orofacial manifestations appearing 
during the early stage of disease,11-15,17-19 and two studies reported 
headache, neck pain, and sore throat during the late stage of 
disease.12,17 Four included studies did not specify early or late 
dissemination for disease stage of the sample populations.8-10,16 
While the majority of reported orofacial manifestations appeared 
during early dissemination among these studies, it is difficult 
to say this is enough evidence to generalize that all orofacial 
manifestations primarily occur during early dissemination of 
Table II. Number of patients with Lyme disease per article compared with frequencies  





















Reported as Lyme disease only; excludes orofacial manifestations
Avery (2006)8 2.7 - 13.1 9.4 18 (67.0)* 9 (33.0)* 27* 25
Cohn (2012)9 7.2 - 13.1** - 81 (69.0)* 36 (31.0)* 117* 113
Dattwyler (1997)11 7 - 85 42.6 87 (62.0)* 53 (38.0)* 140* 147
Gerber (1996)12 1 - 21 7.8 131 (65.0)* 70 (35.0)* 201* 187
Liveris (2002)18 21 - 72 46.6 23 (46.0)* 27 (54.0)* 50* 44
Nadelman (1996)13 16 - 76 43 49 (62.0)* 30 (38.0)* 79* 71
Reported as Lyme disease and orofacial manifestations combined
Payder-Darian (2017)14 7.2 - 13.1** 9.8 unclear unclear 204 204
Peltomaa (2004)15 4 - 74 - 25 (53.0) 22 (47.0) 47 104
Smouha (1997)16 5 - 69 32 30 (60.0) 20 (40.0) 50 55
Belman (1992)17 4 - 14 8.2 5 (71.4) 2 (28.5) 8* 9
Cook (1997)10 3 - 18 10 18 (72.0) 7 (28.0) 25 49
Jain (1996)19 6 - 60 26.3 1 (33.0) 2 (67.0) 3 6
*Number includes those with Lyme disease, does not exclude on the basis of whether or not an OM was present. 
**IQR=reported as interquartile range
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the disease. Future research should include 
specific details about the timeframe of when 
signs and symptoms appear in the disease 
process so that a pattern of correlation may 
be identified over time. Oral health care 
providers with a keen awareness of the role of 
these oral manifestations could refer a patient 
for medical examination when Lyme disease 
is suspected, increasing the chances of making 
a timely diagnosis.
A total of 951 patients were confirmed to 
have Lyme disease across the twelve studies. 
Headache and facial palsy were reported most 
frequently while temporomandibular joint 
arthralgia and altered taste were reported 
the least. Low frequencies of neck stiffness 
and temporomandibular joint arthralgia 
Table III a. Reported orofacial manifestations in confirmed cases of Lyme disease per article
Manifestation: Avery8 Cohn9 Cook10 Dattwyler11 Gerber12




n=55 (23%) early stage 
n=39 (19%) early stage 
n=4 (2%) late stage
Facial palsy n=9 (33.0%); 1 was bilateral n=57 (70.0%)
n=4 (56.0%) right side; 
n=11 (44.0%) left side;
Duration was 2-20 weeks; 
average was 5.24 weeks
n=10 (7%) n=6 (3%) early stage







n=16 (8.0%) early stage 
n=11 (5.0%) early stage 
n=2 (1%) late stage
Neck pain/
arthralgia n=8 (32.0%)
n=34 (17.0%) early stage 
n=19 (9.0%) early stage 
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a single EM rash, 26.0% 
(n=49) had it on the head 
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EM rash on head/neck 
occurred significantly more 
in younger patients (mean 





































































Figure 2. Frequencies of orofacial manifestations 
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was a surprising finding since the review process revealed 
several articles and case studies which reported those two 
symptoms as primary orofacial manifestations.7,24-34 However, 
case studies were excluded from this systematic review, due to 
the high for risk of bias. Considering that neck stiffness and 
temporomandibular joint arthralgia appeared in several case 
studies and have been recognized by the CDC as Lyme disease 
symptoms,2 they may merit further study.
Avery et al, devised a statistical model to help predict Lyme 
meningitis and stated that odds ratios for headaches can serve 
as an independent predictor of the condition and found that 
headache duration was an independent predictor of Lyme 
meningitis in children in an endemic region.8 This model 
allowed practitioners to calculate the probability from .01 to 
.99 of children having Lyme meningitis.8 Each additional day 
of headache duration increased the odds ratio of having Lyme 
disease by 0.136.8 The Avery prediction model was compared 
against a “rule of 7’s” prediction model devised by Cohn et al. 
This prediction model classifies suspicious cases as “low risk” 
when 3 of the following criteria are met: “<7 days of headache, 
<70% cerebrospinal fluid mononuclear cells, and absence of 
seventh or other cranial nerve palsy.”9 Cohn et al reported 
that both the Avery model and the rule of 7’s performed well 
when applied to a sample population of children. However, 
the rule of 7’s model had higher sensitivity (96% [95% CI: 
90%-99%]) compared to the Avery model (83% [95% CI: 
75%-89%]); and fewer misclassifications when assessing 
patient risk for Lyme disease.9  
Smouha et al applied a researcher-designed clinical 
probability scale compared against serology test results to 
determine if clinical signs and symptoms could accurately 
assess Lyme disease probability.16 The researchers defined 
clinical probabilities of Lyme disease signs and symptoms 
including orofacial manifestations: “definite” probability 
(erythema migrans rash), “high” probability (headache and stiff 
neck), “intermediate” probability (arthralgias), and “possible” 
(headache alone).16 However, they concluded that the majority 
of disease predictors could not be made solely based on clinical 
data, which contrasts findings from Avery’s prediction model 
and Cohen’s rule of 7’s model.16 Risks or odds ratios for orofacial 
manifestations should be investigated by validated prediction 
models to determine whether they can assist health care providers 
who encounter suspicious cases. Since patients presenting with 
orofacial manifestations are considered medical emergencies, 
the ability for oral health care providers to apply risk prediction 
models until serology test results are available, and may help 
reduce unnecessary antibiotic prescriptions, invasive medical 
procedures and support timely referrals.  
Generalizability of this systematic review is limited 
because studies of populations outside of the US were not 
included as Lyme disease variants in other countries may 
differ from those found in the US. Additionally, the Cochrane 
Data Collection Form for Randomized Control Trials and 
Non-randomized Control Trials was modified as there were 
few randomized control trials identified in the literature that 
met the inclusion criteria.    
Table III b. Reported orofacial manifestations in confirmed cases of Lyme disease per article
Manifestation: Jain19 Liveris18 Nadelman13 Paydar-Darian14 Peltomaa15 Smouha16 Belman17
Headache n=1 n=19 (38.0%)
n=33 
(42.0%) n=33 (70.0%) n=5 (10.0%) n=6 (75.0%)
Facial palsy
n=3;  
2 were unilateral; 
1 was bilateral













TMJ arthralgia n=2 (2%)
Altered taste n=1





arthralgia n=1 n=7 (9.0%) n=1 (12.5%)
Head/neck  
EM rash
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Future research focused on the eight orofacial mani-
festations associated with Lyme disease as presented in 
oral health care settings is needed. Additionally, there 
were other less common orofacial manifestations of Lyme 
disease reported as case studies that were not included in 
this review. A systematic review of case studies could be 
helpful to investigate the phenomenon of these less common 
manifestations. Case-control studies of integrated electronic 
medical and dental records could be conducted to investigate 
the frequencies of orofacial manifestations of confirmed Lyme 
disease cases against healthy cases from endemic states to 
support evidence-based decision making for all health care 
providers. Future studies should also investigate the efficacy 
of integrated electronic medical and dental records to improve 
the interprofessional collaboration of health care professionals 
for the management of patients with Lyme disease.  
Conclusion
This systematic review researched orofacial manifestations 
of Lyme disease that could be recognized by oral health care 
providers. Eight orofacial manifestations of Lyme disease 
have been well documented in the literature. Ongoing 
research regarding the orofacial manifestations of Lyme 
disease is needed so that this medical phenomenon can be 
well understood by dental professionals in order to best serve 
their patients.  
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